Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
0Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
Lakefront Biotherapeutics NV (GLPG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
2Total relationships
0Distinct source URLs
2High confidence
0.900Average confidence
2026-07-12Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Lakefront Biotherapeutics NV Suppliers
No suppliers on recordLakefront Biotherapeutics NV does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Lakefront Biotherapeutics NV Customers
No clients on recordLakefront Biotherapeutics NV does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.
Lakefront Biotherapeutics NV Debt Obligations
Instrument
Description
Confidence
Evidence
GLPG-DEBT
Debt stack $7.5M
90%
Market cache reports total debt of $7.5M.
Lakefront Biotherapeutics NV Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Lakefront Biotherapeutics NV.
Lakefront Biotherapeutics NV Ownership
Holder
Name
Confidence
Evidence
GLPG-OWNER-GILEAD-SCIENCES-INC
GILEAD SCIENCES, INC.
90%
13F overlay lists GILEAD SCIENCES, INC. as top holder; 92 tracked holders.
